This application is to renew an NINDS P30 Institutional Center Core, the NINDS Informatics Center for Neurogenetics and Neurogenomics, ICNN. The ICNN, founded in 2009, facilitates research in genetics and genomics for members of the large and highly interactive neuroscience community at UCLA. Over the past funding cycle, ICNN has 1) accelerated the progress of ten projects from eight NINDS-funded investigators specified in the initial application; 2) through an ARRA supplement and a sales and service agreement, extended its scope and support to additional neuroscientists at UCLA, so that is it is now involved in one third of all the NINDS R01s awarded to UCLA neuroscientists, essentially all the ones encompassing genomic studies; 3) contributed to 29 publications (+8 submitted), and multiple successful grant applications, including mentoring on training awards; and 4) expanded its faculty and analysis portfolio, to emphasize collaborations between leaders in computational biology and neurogenetics, and the implementation of innovative methods for data analysis. In summary, ICNN, in its initial award period, laid the foundation for a long-term, self- sustained entity supporting genomics neuroscience research at UCLA and has facilitated a number of projects and training grants. With an expanded faculty and a solid computational infrastructure put in place in the previous funding cycle, ICNN proposes in the renewal to continue to support NINDS grants (15 from 9 named users), to continue to develop innovative genetics and genomics approaches, and to continue to foster neurogenetics and neurogenomics for the neuroscience community at UCLA.

Public Health Relevance

Scientists are increasingly focusing their efforts to understand and devise better treatments for brain diseases on investigations of the genomes of humans and other mammals, and are generating vast amounts of data that are overwhelming the capacity of individual laboratories to conduct optimal analyses and adequately manage information. Over the past five years, the UCLA Informatics Center for Neurogenetics and Neurogenomics (ICNN) has provided a shared resource for sophisticated data analyses and computing facilities for investigators who are using genetics and genome science in studies of a wide range of devastating brain diseases at UCLA. This application is to renew support to this Center which has become an invaluable resource for neuroscience at UCLA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS062691-09
Application #
9544334
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Lavaute, Timothy M
Project Start
2009-08-01
Project End
2019-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lee, C Y Daniel; Daggett, Anthony; Gu, Xiaofeng et al. (2018) Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models. Neuron 97:1032-1048.e5
Cobos, Enrique J; Nickerson, Chelsea A; Gao, Fuying et al. (2018) Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling. Cell Rep 22:1301-1312
Anderson, Mark A; O'Shea, Timothy M; Burda, Joshua E et al. (2018) Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature 561:396-400
Ramos, Eliana Marisa; Carecchio, Miryam; Lemos, Roberta et al. (2018) Primary brain calcification: an international study reporting novel variants and associated phenotypes. Eur J Hum Genet 26:1462-1477
Laks, Dan R; Oses-Prieto, Juan A; Alvarado, Alvaro G et al. (2018) A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma. Neuro Oncol 20:764-775
Garrett, Matthew; Sperry, Jantzen; Braas, Daniel et al. (2018) Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities. Cancer Metab 6:4
Gu, Lei; Bok, Dean; Yu, Fei et al. (2018) Downregulation of splicing regulator RBFOX1 compromises visual depth perception. PLoS One 13:e0200417
Chen, Jason A; Fears, Scott C; Jasinska, Anna J et al. (2018) Neurodegenerative disease biomarkers A?1-40, A?1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy. Brain Behav 8:e00903
Sayed, Faten A; Telpoukhovskaia, Maria; Kodama, Lay et al. (2018) Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A 115:10172-10177
Hibar, D P; Westlye, L T; Doan, N T et al. (2018) Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry 23:932-942

Showing the most recent 10 out of 94 publications